Company / Revenue
INOVIO PHARMACEUTICALS, INC. Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$217.8K
FY2025
5-year range
$217.8K / $7.4M
FY2021-FY2025
Trend
-73.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has declined for 3 consecutive years, from $7M in FY2022 to $217,756 in FY2025.
Based on SEC 10-K filings.
$217,756 in FY2025 with a 5-year CAGR of -62.8%.
Declined from $2M to $217,756 over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -69.1%
- 5-Year CAGR
- -62.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- INOVIO PHARMACEUTICALS, INC.'s revenue has declined for 3 consecutive years.
- 5-year CAGR of -62.8%, indicating a declining trend.
- In FY2025, revenue decreased 73.8% year-over-year.
- Peak revenue was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $217.8K | -73.8% |
| FY2024 | $832.0K | -53.1% |
| FY2023 | $1.8M | -76.1% |
| FY2022 | $7.4M | +80.2% |
| FY2021 | $4.1M | -86.5% |
| FY2020 | $30.5M | -27.8% |
| FY2019 | $42.2M | +19.4% |
| FY2018 | $35.4M | -12.8% |
| FY2017 | $40.6M | +288.0% |
| FY2016 | $10.5M | -22.4% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026